A Missouri jury is now hearing evidence in the state’s fourth trial involving the alleged link between Johnson & Johnson talcum powder products and ovarian cancer. During opening statements last week, a plaintiff’s attorney asserted that Johnson & Johnson’s “love of money” led it to ignore a growing body of research linking the genital application of …